Integral Diagnostics
Integral Diagnostics, a leading provider of diagnostic imaging services, is headquartered in Australia and operates extensively across major regions including Queensland, Victoria, and Western Australia. Founded in 2006, the company has established itself as a key player in the healthcare sector, focusing on high-quality radiology services. Specialising in a range of imaging modalities such as MRI, CT, and ultrasound, Integral Diagnostics is recognised for its commitment to advanced technology and patient care. The company’s unique approach combines state-of-the-art equipment with a team of highly skilled professionals, ensuring accurate and timely diagnoses. With a strong market position, Integral Diagnostics has achieved significant milestones, including numerous accreditations and partnerships that enhance its service offerings. As a trusted name in the industry, Integral Diagnostics continues to set benchmarks for excellence in diagnostic imaging.
DitchCarbon Score
How does Integral Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Integral Diagnostics's score of 18 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Integral Diagnostics's reported carbon emissions
In 2022, Integral Diagnostics reported total greenhouse gas emissions of approximately 588,100 kg CO2e for Scope 1 and about 9,109,500 kg CO2e for Scope 2. The company has not disclosed any emissions data for 2023, nor have they provided information on Scope 3 emissions. Over the past few years, Integral Diagnostics has shown a commitment to reducing its carbon footprint. In 2021, their Scope 1 emissions were approximately 508,200 kg CO2e, while Scope 2 emissions were about 7,028,800 kg CO2e. In 2020, the figures were approximately 432,700 kg CO2e for Scope 1 and about 6,716,500 kg CO2e for Scope 2. This indicates a trend of increasing emissions in 2022 compared to previous years, particularly in Scope 2. Despite the lack of specific reduction targets or initiatives disclosed, Integral Diagnostics is actively monitoring its emissions per patient exam, with Scope 1 emissions at 0.3 kg CO2e and Scope 2 emissions at 3.5 kg CO2e per exam in 2023. The company continues to engage in climate commitments, although specific pledges or targets have not been outlined.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 432,700 | 000,000 | 000,000 |
| Scope 2 | 6,716,500 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Integral Diagnostics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
